Warren Buffett's big bet on kidney dialysis provider DaVita may finally be primed to start paying off, albeit after five frustrating years of negative returns.
Berkshire Hathaway Inc. (BRK.A) (BRK.B) has been a patient holder of about 21.6% of the shares of kidney dialysis provider DaVita Inc(DVA) for quite some timeIt hasn't worked out wellThe non-dividend paying stock hovers near five-year lowsAnd DaVita's EPS remain lower than in 2013. A pending sale of DVA's medical group to UnitedHealth Group In...
Read the full story and get access to the Real Money Pro trading floor.
There's no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.